AAAAAA

   
Results: 1-9 |
Results: 9
Early prognostic indicators of outcome in ischemic childhood stroke
Authors: Delsing, BJP Catsman-Berrevoets, CE Appel, IM
Citation: Bjp. Delsing et al., Early prognostic indicators of outcome in ischemic childhood stroke, PED NEUROL, 24(4), 2001, pp. 283-289
Clinical evaluation of conversational speech fluency in the acute phase ofacquired childhood aphasia: Does a fluency/nonfluency dichotomy exist?
Authors: van Dongen, HR Paquier, PF Creten, WL van Borsel, J Catsman-Berrevoets, CE
Citation: Hr. Van Dongen et al., Clinical evaluation of conversational speech fluency in the acute phase ofacquired childhood aphasia: Does a fluency/nonfluency dichotomy exist?, J CHILD NEU, 16(5), 2001, pp. 345-351
Netherlands Society of Child Neurology (NVKN) Secretariat: Netherlands Society of Child Neurology
Authors: Catsman-Berrevoets, CE
Citation: Ce. Catsman-berrevoets, Netherlands Society of Child Neurology (NVKN) Secretariat: Netherlands Society of Child Neurology, CLIN NEUROL, 102(4), 2000, pp. 268-272
Clinical utility of the judgment of line orientation test and facial recognition test in children with acquired unilateral cerebral lesions
Authors: Paquier, PF van Mourik, M Van Dongen, HR Catsman-Berrevoets, CE Creten, WL Stronks, DL
Citation: Pf. Paquier et al., Clinical utility of the judgment of line orientation test and facial recognition test in children with acquired unilateral cerebral lesions, J CHILD NEU, 14(4), 1999, pp. 243-248
D-2-hydroxyglutaric aciduria: Biochemical marker or clinical disease entity?
Authors: van der Knaap, MS Jakobs, C Hoffmann, GF Nyhan, WL Renier, WO Smeitink, JAM Catsman-Berrevoets, CE Hjalmarson, O Vallance, H Sugita, K Bowe, CM Herrin, JT Craigen, WJ Buist, NRM Brookfield, DSK Chalmers, RA
Citation: Ms. Van Der Knaap et al., D-2-hydroxyglutaric aciduria: Biochemical marker or clinical disease entity?, ANN NEUROL, 45(1), 1999, pp. 111-119
First-trimester diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) using PPT enzyme assay and CLN1 mutation analysis
Authors: de Vries, BBA Kleijer, WJ Keulemans, JLM Voznyi, YV Franken, PF Eurlings, MCM Galjaard, RJ Losekoot, M Catsman-Berrevoets, CE Breuning, MH Taschner, PEM van Diggelen, OP
Citation: Bba. De Vries et al., First-trimester diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) using PPT enzyme assay and CLN1 mutation analysis, PRENAT DIAG, 19(6), 1999, pp. 559-562
Tumour type and size are high risk factors for the syndrome of "cerebellar" mutism and subsequent dysarthria
Authors: Catsman-Berrevoets, CE Van Dongen, HR Mulder, PGH Geuze, DPY Paquier, PF Lequin, MH
Citation: Ce. Catsman-berrevoets et al., Tumour type and size are high risk factors for the syndrome of "cerebellar" mutism and subsequent dysarthria, J NE NE PSY, 67(6), 1999, pp. 755-757
Angelman syndrome: AS phenotype correlated with specific EEG pattern may result in a high detection rate of mutations in the UBE3A gene
Authors: van den Ouweland, AMW Bakker, PLG Halley, DJJ Catsman-Berrevoets, CE
Citation: Amw. Van Den Ouweland et al., Angelman syndrome: AS phenotype correlated with specific EEG pattern may result in a high detection rate of mutations in the UBE3A gene, J MED GENET, 36(9), 1999, pp. 723-724
A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants
Authors: Voznyi, YV Keulemans, JLM Mancini, GMS Catsman-Berrevoets, CE Young, E Winchester, B Kleijer, WJ van Diggelen, OP
Citation: Yv. Voznyi et al., A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants, J MED GENET, 36(6), 1999, pp. 471-474
Risultati: 1-9 |